These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3001569)

  • 1. The opioid receptors in the hamster vas deferens are of the delta-type.
    McKnight AT; Corbett AD; Marcoli M; Kosterlitz HW
    Neuropharmacology; 1985 Nov; 24(11):1011-7. PubMed ID: 3001569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hamster vas deferens contains delta-opioid receptors.
    McKnight AT; Corbett AD; Marcoli M; Kosterlitz HW
    Neuropeptides; 1984 Dec; 5(1-3):97-100. PubMed ID: 6099523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
    Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
    Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of delta-opioid receptors in the hamster vas deferens.
    Sheehan MJ; Hayes AG; Tyers MB
    Eur J Pharmacol; 1986 Oct; 130(1-2):57-64. PubMed ID: 3023115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
    Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE
    Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two new opioid delta-receptor ligands: a highly selective agonist and a potent selective antagonist in in vitro isolated preparations.
    Ueki M; Aoki K; Kajiwara M; Shinozaki K; Inoue H; Oka T
    Jpn J Pharmacol; 1984 Dec; 36(4):485-9. PubMed ID: 6098760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the delta-opioid receptor on the hamster vas deferens.
    Miller L; Shaw JS
    Neuropeptides; 1985 Dec; 6(6):531-6. PubMed ID: 3001576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro study of the interaction of salmon calcitonin with mu, delta and kappa opioid agonists.
    Martín MI; Alfaro MJ; Goicoechea C; Colado MI
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):324-8. PubMed ID: 8386807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
    Cohen ML; Mendelsohn LG; Mitch CH; Zimmerman DM
    Receptor; 1994; 4(1):43-53. PubMed ID: 8038706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of evidence for epsilon-opioid receptors in the rat vas deferens.
    Sheehan MJ; Hayes AG; Tyers MB
    Eur J Pharmacol; 1988 Sep; 154(3):237-45. PubMed ID: 2853057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of activity of kappa receptor agonists in the rabbit vas deferens.
    Hayes A; Kelly A
    Eur J Pharmacol; 1985 Apr; 110(3):317-22. PubMed ID: 2988982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
    Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of opioids in a circular muscle-myenteric plexus preparation of guinea-pig ileum.
    Johnson SM; Costa M; Humphreys CM; Shearman R
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):419-24. PubMed ID: 2829034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity profiles of dalargin and its analogues in mu-, delta- and kappa-opioid receptor selective bioassays.
    Pencheva N; Pospisek J; Hauzerova L; Barth T; Milanov P
    Br J Pharmacol; 1999 Oct; 128(3):569-76. PubMed ID: 10516634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diprenorphine has agonist activity at opioid kappa-receptors in the myenteric plexus of the guinea-pig ileum.
    Traynor JR; Corbett AD; Kosterlitz HW
    Eur J Pharmacol; 1987 May; 137(1):85-9. PubMed ID: 3038579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene.
    Maldonado R; Severini C; Matthes HW; Kieffer BL; Melchiorri P; Negri L
    Br J Pharmacol; 2001 Apr; 132(7):1485-92. PubMed ID: 11264242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.
    Elliott J; Traynor JR
    Br J Pharmacol; 1995 Mar; 114(5):1064-8. PubMed ID: 7780641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the kappa-opioid activity of a series of 6,7-benzomorphans in the rabbit vas deferens.
    Verlinde C; De Ranter C
    Eur J Pharmacol; 1988 Aug; 153(1):83-7. PubMed ID: 2850928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate receptors in the rat vas deferens.
    Smith CF; Rance MJ
    Life Sci; 1983; 33 Suppl 1():327-30. PubMed ID: 6319887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors.
    Rogers H; Hayes AG; Birch PJ; Traynor JR; Lawrence AJ
    J Pharm Pharmacol; 1990 May; 42(5):358-9. PubMed ID: 1976787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.